Xortx welcomes new member to the board of directors

Calgary, alberta, jan. 02, 2024 (globe newswire) -- xortx therapeutics inc. ("xortx" or the “company”) (nasdaq: xrtx | tsxv: xrtx | frankfurt: anu), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, welcomes mr. patrick treanor to the board of directors and announces the resignation of ian klassen, both effective december 31, 2023.
XRTX Ratings Summary
XRTX Quant Ranking